日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Nocardia farcinica Probable rRNA maturation factor (NFA_14330) CSB-YP713672NAAA
CSB-EP713672NAAA
CSB-BP713672NAAA
CSB-MP713672NAAA
CSB-EP713672NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica Valine--tRNA ligase (valS), partial CSB-YP713673NAAA
CSB-EP713673NAAA
CSB-BP713673NAAA
CSB-MP713673NAAA
CSB-EP713673NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica Probable phosphoketolase (NFA_13300), partial CSB-YP713674NAAA
CSB-EP713674NAAA
CSB-BP713674NAAA
CSB-MP713674NAAA
CSB-EP713674NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica Probable cytochrome c oxidase subunit 1-beta (ctaD2), partial CSB-YP713675NAAA
CSB-EP713675NAAA
CSB-BP713675NAAA
CSB-MP713675NAAA
CSB-EP713675NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica ATP synthase subunit beta (atpD) CSB-YP713676NAAA
CSB-EP713676NAAA
CSB-BP713676NAAA
CSB-MP713676NAAA
CSB-EP713676NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica Glycerol kinase (glpK) CSB-YP713677NAAA
CSB-EP713677NAAA
CSB-BP713677NAAA
CSB-MP713677NAAA
CSB-EP713677NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica 60 kDa chaperonin 1 (groL1), partial CSB-YP713678NAAA
CSB-EP713678NAAA
CSB-BP713678NAAA
CSB-MP713678NAAA
CSB-EP713678NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica 30S ribosomal protein S11 (rpsK) CSB-YP713679NAAA
CSB-EP713679NAAA
CSB-BP713679NAAA
CSB-MP713679NAAA
CSB-EP713679NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica Translation initiation factor IF-1 (infA) CSB-YP713680NAAA
CSB-EP713680NAAA
CSB-BP713680NAAA
CSB-MP713680NAAA
CSB-EP713680NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica 50S ribosomal protein L30 (rpmD) CSB-YP713681NAAA
CSB-EP713681NAAA
CSB-BP713681NAAA
CSB-MP713681NAAA
CSB-EP713681NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica 50S ribosomal protein L18 (rplR) CSB-YP713682NAAA
CSB-EP713682NAAA
CSB-BP713682NAAA
CSB-MP713682NAAA
CSB-EP713682NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica 50S ribosomal protein L24 (rplX) CSB-YP713683NAAA
CSB-EP713683NAAA
CSB-BP713683NAAA
CSB-MP713683NAAA
CSB-EP713683NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica 30S ribosomal protein S19 (rpsS) CSB-YP713684NAAA
CSB-EP713684NAAA
CSB-BP713684NAAA
CSB-MP713684NAAA
CSB-EP713684NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica 50S ribosomal protein L23 (rplW) CSB-YP713685NAAA
CSB-EP713685NAAA
CSB-BP713685NAAA
CSB-MP713685NAAA
CSB-EP713685NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica Acetaldehyde dehydrogenase 1 (NFA_4660) CSB-YP713686NAAA
CSB-EP713686NAAA
CSB-BP713686NAAA
CSB-MP713686NAAA
CSB-EP713686NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica UPF0133 protein NFA_2940 (NFA_2940) CSB-YP713687NAAA
CSB-EP713687NAAA
CSB-BP713687NAAA
CSB-MP713687NAAA
CSB-EP713687NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica Serine--tRNA ligase (serS) CSB-YP713688NAAA
CSB-EP713688NAAA
CSB-BP713688NAAA
CSB-MP713688NAAA
CSB-EP713688NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nocardia farcinica Chromosomal replication initiator protein DnaA (dnaA), partial CSB-YP713689NAAA
CSB-EP713689NAAA
CSB-BP713689NAAA
CSB-MP713689NAAA
CSB-EP713689NAAA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Cellulose synthase-like protein D5 (CSLD5), partial CSB-YP713690OFG
CSB-EP713690OFG
CSB-BP713690OFG
CSB-MP713690OFG
CSB-EP713690OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oryza sativa subsp. japonica Cyclin-dependent kinase F-1 (CDKF-1) CSB-YP713691OFG
CSB-EP713691OFG
CSB-BP713691OFG
CSB-MP713691OFG
CSB-EP713691OFG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×